Elevated acylcarnitines indicate disrupted mitochondrial β-oxidation and energy stress, while increased circulating triglycerides—particularly in viral CAP and COVID-19—are consistent with hepatic lipogenesis driven by inflammatory cytokines such as interleukin -6 (IL-6) and tumor necrosis factor alpha (TNF-α) [12,18]. The gene discussed is IL6; the disease is COVID-19.